Li LI;BEIJING RONGXIANG INSTITUTE OF REGENERATIVE MEDICINE CO., LTD.
发明人:
Li LI
申请号：
US16763434
公开号：
US20200315974A1
申请日:
2018.11.13
申请国别(地区):
US
年份:
2020
代理人:
摘要：
An application of an oral pharmaceutical composition in manufacturing of a medication for regulating fibroblast growth and treating or preventing organ fibrosis. The pharmaceutical composition comprises a homogeneous mixture of an edible oil, beeswax, and β-sitosterol, wherein the beeswax forms microcrystals, and on the basis of the total weight of the composition, the content of the beeswax is 0.5-50% and the content of β-sitosterol is 0.1%-20%.
